Skip to Content

Amphadase Approval History

FDA Approved: Yes (First approved October 26, 2004)
Brand name: Amphadase
Generic name: hyaluronidase
Dosage form: Injection
Company: Amphastar Pharmaceuticals, Inc
Treatment for: Adjuvant to increase the absorption and dispersion of other injected drugs

Amphadase (hyaluronidase) used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.

Development History and FDA Approval Process for Amphadase

DateArticle
Oct 26, 2004Approval Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide